Kent, United Kingdom

Anne Hodgson

This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2002-2004.


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • Dartford, GB (2002)
  • Kent, GB (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anne Hodgson: Innovator in Pharmaceutical Chemistry

Introduction

Anne Hodgson is a distinguished inventor based in Kent, GB. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. Her work focuses on innovative chemical processes that have the potential to impact medical therapy.

Latest Patents

One of Anne Hodgson's latest patents is for a chemical process involving Form VI 5,6-dichloro-2-(isopropylamino)-1-(&bgr;-l-ribofuranosyl)-1H-benzimidazole. This invention relates to pharmaceutical compositions comprising this compound and their use in medical therapy. Her research aims to enhance the efficacy of treatments through novel chemical formulations.

Career Highlights

Anne Hodgson is currently employed at SmithKline Beecham Corporation, where she continues to advance her research in pharmaceutical innovations. Her career is marked by a commitment to developing new therapeutic solutions that address pressing medical needs.

Collaborations

Throughout her career, Anne has collaborated with notable colleagues, including Lian-Feng Huang and David Colclough. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Anne Hodgson's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medical therapy. Her patents and ongoing research continue to pave the way for advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…